Can it possibly be a coincidence that the American Medical Association just “officially” designated obesity as a disease, and we now also have a new FDA approved drug to treat it? Belvig, which is maufacturered by Arena Pharmaceuticals, is the newest drug option to treat obesity and overweight. Overweight people, however, can only get the drug if their weight condition is accompanied by another health risk like high blood pressure, high cholesterol or type 2 diabetes.
Belvig works by controlling appetite, and it does it by regulating brain receptors for serotonin. It’s what’s called a “serotonergic” drug.
In trials, the type 2 diabetics who took Belvig lost an average of 12 pounds, which frankly, isn’t that much weight. The drug is supposed to be taken along with a restrictive diet and exercise. Typical side effects include headache, nausea, fatigue and constipation. Of course, you can just do the restrictive diet and exercise and skip all the unpleasant side effects.
The link above is for a Huffington Post article by David Katz MD, who advocates fighting obesity the old-fashioned way, with feet and forks rather than drugs and surgery. Is a long-term drug therapy really the best and most harmless solution? Katz thinks big pharma companies are the big winners here.